Nasus Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	96	-	-
Enterprise Value	97	-	-
Debt / Equity Ratio	-0.56	-0.56	-0.65
Debt / EBITDA Ratio	-1.20	-1.20	-2.45
Debt / FCF Ratio	-2.71	-2.71	-2.39
Quick Ratio	0.08	0.08	0.05
Interest Coverage	-51.83	-51.83	-20.45
Return on Equity (ROE)	47.70%	47.70%	27.68%
Return on Assets (ROA)	-213.67%	-213.67%	-236.71%
Return on Capital (ROIC)	76.45%	76.45%	85.60%
Return on Capital Employed (ROCE)	46.79%	46.79%	26.39%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).